← Open Payments lookup

MICHELLE PRICE: Open Payments

NPI 1992057111 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,623 in 169 payments from 25 companies in 2025. Trend: 2023 $2,625 · 2024 $3,034 · 2025 $3,623

Food & beverage: $3,624
CompanyPaymentsAmount
GlaxoSmithKline, LLC.33$642
AstraZeneca Pharmaceuticals LP19$406
Mallinckrodt Hospital Products Inc.14$315
Boehringer Ingelheim Pharmaceuticals, Inc.11$257
GENZYME CORPORATION11$255
Grifols USA, LLC9$237
Amgen Inc.15$225
Regeneron Healthcare Solutions, Inc.8$189
Takeda Pharmaceuticals U.S.A., Inc.6$171
Merck Sharp & Dohme LLC7$143

Products named: DUPIXENT, TRELEGY ELLIPTA, ACTHAR, TEZSPIRE, NUCALA, Prolastin-C Liquid, OFEV, GLASSIA.

Industry payments across AL — which companies pay providers there.